Genmab A GNMSF

NASDAQ GNMSF

$337.00 +2.00 (+0.60%)

As of: Aug 21, 2026 · 10:11 AM EDT

Genmab A/S (GNMSF) Net Income towards Common Stockholders Growth (1y) (2019 - 2026)

Genmab A/S (GNMSF) Net Income towards Common Stockholders Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

Historic Data

Download Data

Date	Value
Jun 30, 2026	-42.94%
Mar 31, 2026	7.29%
Sep 30, 2025	19.99%
Jun 30, 2025	34.43%
Mar 31, 2025	12.37%
Sep 30, 2020	-100.00%
Dec 31, 2019	67.26%

Genmab A

NASDAQ: GNMSF

$337.00 ▲ +2.00 (+0.60%)

Aug 21, 2026 · 10:11 AM EDT